Home - Onco'Zine

First Targeted Therapy Approved for Rare Mutation of Gastrointestinal Stromal Tumors

Peter Hofland, Ph.D - January 10, 2020

The Nuts & Bolts of High Intensity Focal Ultrasound

Scientists Discover Previously Unknown Role of Immune Signaling Protein in Pancreatic Cancer

For the First Time Double-Digit Survival Rates Reported in Pancreatic Cancer

Excessive and Binge Drinking Surprisingly Common Among Cancer Survivors

FEATURED

The Nuts & Bolts of High Intensity Focal Ultrasound

John Russell Valvo, MD - January 10, 2020

Personalizing Cancer Treatment: Why Adaptive Therapy Isn’t There Yet

Yves Archambault - August 21, 2019

Common Myths about Colorectal Cancer Surgery Dispelled

Peter Hofland, Ph.D - July 22, 2019

Lung Cancer Among the Most Likely Conditions to Harm Patients who are Misdiagnosed

Peter Hofland, Ph.D - July 12, 2019

Debunking the 7 Most Common Misconceptions of Colorectal Cancer

Padma Sundar - March 19, 2019

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal - March 5, 2019

CONFERENCE COVERAGE

Advances in Bispecific Antibody Development are Leading to an Evolution in Anti-cancer Drugs

Editorial Team - December 19, 2019

SABCS 2019: Circulating Tumor DNA may be a Predictor of Recurrence of Triple-negative Breast...

Peter Hofland, Ph.D - December 14, 2019

SABCS 2019: Oral Paclitaxel Yields Superior Results Compared to Intravenous Paclitaxel in mBC

Danielle Garcia - December 13, 2019

Residual Cancer Burden After Neoadjuvant Chemotherapy can be a Predictor of Breast Cancer Outcomes

Danielle Garcia - December 13, 2019

SABCS 2019: Trastuzumab Deruxtecan Achieves Clinically Meaningful and Durable Response

Peter Hofland, Ph.D - December 13, 2019

SABCS 2019: Women at Elevated Risk of Breast Cancer May Benefit From Anti-inflammatory Drugs

Peter Hofland, Ph.D - December 13, 2019

EDITORIAL

The Nuts & Bolts of High Intensity Focal Ultrasound

John Russell Valvo, MD - January 10, 2020

Celebrate Being a Holiday Hero—How to Build Your Resilience Despite Working Holidays in Oncology

Gary R. Simonds, MD, MHCDS - December 23, 2019

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More Options are Needed.

Andrea Maddox-Smith - December 20, 2019

Broadening the Applicability of CAR-T Immunotherapy to Treat the Untreatable

Filippo Petti - October 24, 2019

Decreasing Breast Cancer False Positives with NV-VPAC1-PET Scan Technology

Jill Helmke - September 25, 2019

Transparency and Openness – A Must in the Murky World of Drug Pricing

LaMar Williams, Jr. - August 30, 2019

ERIC ROSENTHAL REPORTS

Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?

Eric T. Rosenthal - March 5, 2019

Dr. Brawley Goes to Baltimore?and Washington

Eric T. Rosenthal - January 23, 2019

Jose Baselga Resigns as Co-Editor-in-Chief of Cancer Discovery

Eric T. Rosenthal - December 19, 2018

Professional Societies Disclose Their Disclosure Policies, But Why Won?t Some Discuss Them?

Eric T. Rosenthal - November 20, 2018

Otis Brawley Discusses Life After Leaving the American Cancer Society

Eric T. Rosenthal - November 16, 2018

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Eric T. Rosenthal - October 9, 2018

EXPERT INTERVIEWS

Knowledge Alone is Not Enough to Defeat Cancer

Peter Hofland, Ph.D - November 2, 2018

Case Reports Show Potential of Cancer Immunotherapy for the Treatment of a Rare Form...

Sonia Portillo - July 11, 2017

An Intelligent Way to Deliver High Doses of a Very Potent Cytotoxic Agent

Shaun Mehr, Associate Publisher - November 21, 2016